Culprit Medications and Risk Factors Associated with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Population-Based Nested Case

Culprit Medications and Risk Factors Associated with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Population-Based Nested Case–Control Study

Published:2022-02-04 Issue:2 Volume:23 Page:257-266
ISSN:1175-0561
Container-title:American Journal of Clinical Dermatology
language:en
Short-container-title:Am J Clin Dermatol

Author:

Gronich Naomi^ORCID,Maman David,Stein Nili,Saliba Walid

Publisher

Springer Science and Business Media LLC

Subject

Dermatology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40257-021-00661-0.pdf

Reference39 articles.

1. Gerull R, Nelle M, Schaible T. Toxic epidermal necrolysis and Stevens–Johnson syndrome: a review. Crit Care Med. 2011;39(6):1521–32.

2. Harr T, French LE. Stevens–Johnson syndrome and toxic epidermal necrolysis. Chem Immunol Allergy. 2012;97:149–66.

3. Hsu DY, Brieva J, Silverberg NB, Silverberg JI. Morbidity and mortality of Stevens–Johnson syndrome and toxic epidermal necrolysis in United States adults. J Invest Dermatol. 2016;136:1387–97.

4. Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, et al. Stevens–Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol. 2008;128(1):35–44.

5. Bellón T. Mechanisms of severe cutaneous adverse reactions: recent advances. Drug Saf. 2019;42(8):973–92.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A nationwide study of Stevens–Johnson syndrome and toxic epidermal necrolysis in hospitalized pregnant women in the United States, 2009–2020;JAAD International;2024-09

2. High risk and low prevalence diseases: Stevens Johnson syndrome and toxic epidermal necrolysis;The American Journal of Emergency Medicine;2024-07

3. Hyperuricemia – consequences of not initiating therapy. Benefits and drawbacks of treatment;Rheumatology;2024-07-01

4. Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Analysis of the Russian Database of Spontaneous Reports;Pharmaceuticals;2024-05-24

5. Risk factors for the development of Stevens–Johnson syndrome/toxic epidermal necrolysis following drug administration: a systematic review and meta-analysis;Clinical and Experimental Dermatology;2024-05-15